CLOs on the Move

Medical Tracking Solutions

www.medicaltracking.com

 
Medical Tracking Solutions, a team of medical device industry experts, developed iTraycer to meet the day-to-day challenges of medical device companies. iTraycer is a comprehensive inventory management system that provides real-time tracking of medical devices and biologics – visible by part, lot, and serial numbers – from manufacturer to patient. The system`s multifunctional software facilitates communication and collaboration across the enterprise and enables companies to make critical, fact-based decisions with real-time information. And, iTraycer ensures compliance by addressing the traceability requirements of Unique Device Identification (UDI) regulations.
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

O2 Concepts

O2 Concepts has reimagined non-delivery, stepping forward as the first manufacturer to create a smart POC integrated over the Verizon Network that benefits dealers and patients alike. Dynamic Network Analysis (DNA) allows oxygen providers to monitor all devices remotely for location, usage and performance, as well as troubleshoot to prevent any unnecessary dispatches. DNA Technology™ serves as an additional upgrade to 24/7 reliability and the Oxlife Independence`s standard 5 year warranty. O2 Concepts is privately held with factory operations in Newtown, CT and all products are proudly made in the USA.

UltraSPECT

UltraSPECT is a Merrick, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Maxant Technologies

Maxant Technologies is a Niles, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medical Mobility

Medical Mobility, Inc. is a Goodlettsville, TN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

GT Medical Technologies

Driven to raise the standard of care and improve the lives of patients with brain tumors, a team of brain tumor specialists formed GT Medical Technologies. FDA-cleared GammaTile Therapy is a Surgically Targeted Radiation Therapy (STaRT) for patients undergoing brain tumor removal surgery of newly diagnosed malignant and recurrent brain tumors. This "one-and-done" treatment eliminates the need for one to six weeks of daily external beam radiation therapy, allowing patients to go about their daily lives without the burden of additional trips to the hospital or clinic for ongoing treatment. Since its full market release in the United States in March 2020, GammaTile has been offered in more than 95 hospitals, with more centers being added each month.